Stock·NYSE·Industrials
L3Harris Technologies, Inc. (LHX)
- Market cap
- $48.46B
- P/E
- 26.23
- Dividend yield
- 1.90%
- Street target
- $325.00median of 20 analysts
- 52-week range
- $232.34 $379.23
LHX stock forecast today
Where LHX stands today, and what CleaRank Financial AI makes of it.
LHX at a glance
L3Harris Technologies, Inc. (LHX): Buy, 66/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($250.40 and $306.20).
- Earnings LHX beat estimates in 7 of its last 7 quarters, yet fell the next day after every one of them.
- Insiders Insiders sold $72.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 26.2 against 34.0 for the Industrials sector: a discount to peers (-23%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates L3Harris Technologies, Inc. (LHX) Buy, with a model score of 66/100.
Valuation adds the most to that score. The P/E of 26.23 is 22.8% below the sector median P/E, a discount to peers, and the P/S of 2.11 is 47.3% below the sector median P/S. The trend drags the score down the most, since the price sits 15.01% below its 200-day average and the 50-day average is 18.22% below the 200-day. The 50-day average is $250.40 and the 200-day is $306.20. Across the past year, the price declined 11.24%.
Only on CleaRank
Figures we compute ourselves from LHX's own price, earnings and insider-filing history. Tap one to see it in context.
LHX stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $260.23 is 3.9% above the 50-day simple moving average of $250.40.Price above its 200-day average ›
The price is 15.0% below the 200-day simple moving average of $306.20.50-day average above the 200-day ›
The 50-day average ($250.40) is 18.2% below the 200-day average ($306.20), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 19% of its 52-week range, between $232.34 and $379.23.
LHX share price
Pick a period: each tab shows how far LHX has moved over it, to the last close.
Today's trading
Where LHX sits inside today's range and its 52-week range.
LHX fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 26.23 is 22.8% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 2.11 is 47.2% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $1.9B on revenue of $22.9B, a net margin of 8.1%.Beat estimates in most recent reports ›
LHX beat the EPS estimate in 7 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.90%, or $4.95 a share a year.
Key statistics
The headline figures for LHX.
As of October 26, 2026, LHX trades at $260.23, with a market value of $48.46B, a P/E ratio of 26.23 and a dividend yield of 1.90%.
What the numbers say
CleaRank Financial AI's reading of LHX's valuation, growth and risks.
L3Harris Technologies, Inc. (LHX) has a trailing P/E of 26.23, which is 22.8% below the Industrials median of 34.0. The peer comparison on this page rates that as a discount to peers. Measured against sales, LHX trades at 2.11 times, 47.3% below the sector median of 4.0. To put the size in context, its market capitalisation is $48.5B.
LHX is growing revenue at 8.40%, which is 3.3 percentage points slower than the sector median of 11.7%. Profitability is solid for its size: a net margin of 8.17% and an operating margin of 12.57% turn sales into profit. Return on equity of 9.34% sits below the sector median of 17.8%. Debt-to-equity of 0.53 describes the balance sheet, and the trailing dividend yield of 1.90% works out to $4.95 a share a year.
LHX reported $3.13 a share against an estimate of $2.84 for the July 29, 2026 report, beating the estimate by 10.21%. The share price nonetheless dropped 8.61% in the first session after the report.
Across its last 7 reports, LHX beat the estimate every time, yet the stock fell in the first session after every one of those 7 beats. Looking ahead, analysts expect EPS of $12.09 this fiscal year (growth of 12.6%) and $13.51 the year after (growth of 11.8%).
The price of LHX typically moves 1.37% on a given day, based on the 30-day standard deviation of its daily returns. Its beta against the S&P 500 is 0.51. The price sits 31.38% below the 52-week high of $379.23. Over the last 18 months, insiders sold $72.5M of stock and made no open-market purchases. Sales of this kind are often planned ahead, so they carry less weight than purchases would.
LHX against the Industrials sector
How LHX compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: LHX trades at a notable discount to sector peers (-23%), which may indicate undervaluation or specific company headwinds.
Return vs XLI: Since May 14, 2025, LHX has gained 18.5% against a gain of 18.8% for XLI.
Performance against XLI
LHX and the Industrials sector fund over the same days.
Revenue and earnings
How much LHX sells, and how much of it becomes profit.
Revenue growth: Revenue grew 2.5% in FY2025 to $21.9B, from $21.3B a year earlier.
Profit margin: The net margin was 7.3% in FY2025, up from 7.1% the year before.
Profitable: LHX earned $1.6B in FY2025.
Earnings reality check
Did LHX beat what analysts expected, and how did the stock react?
Earnings record: LHX beat the analyst estimate in 7 of the last 7 quarters.
Market reaction: The stock fell in the first session after 7 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 29, 2026after close | $2.84 | $3.13 | +10.21% | -8.61% | -3.83% |
| Apr 30, 2026after close | $2.57 | $2.72 | +5.84% | -2.24% | -6.04% |
| Jan 29, 2026after close | $2.76 | $2.86 | +3.62% | -3.70% | -3.88% |
| Oct 30, 2025after close | $2.57 | $2.70 | +5.06% | -2.30% | -3.68% |
| Jul 24, 2025after close | $2.50 | $2.78 | +11.20% | -1.44% | +0.59% |
| Apr 24, 2025after close | $2.32 | $2.41 | +3.88% | -0.09% | +1.68% |
| Jan 30, 2025after close | $3.42 | $3.47 | +1.46% | -0.02% | -2.55% |
As of October 26, 2026, LHX has beaten the analyst EPS estimate in 7 of its last 7 reported quarters and fell in the first trading session after 7 of those beats; its latest report, on July 29, 2026, came in 10.21% above the estimate and the stock moved -8.61% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
LHX AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 66.8, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 66.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of LHX
The score, the reasoning behind it, and what could move the price next.
L3Harris Technologies, Inc. (LHX) shows a mixed trend. At $260.23, the stock is 3.93% above its 50-day average of $250.40, yet it sits 15.01% below its 200-day average of $306.20. Within its 52-week range, the price is 12.00% above the low of $232.34 and 31.38% below the high of $379.23, which places it close to the bottom of that range.
Recent gains sit against a weaker longer record: the price rose 9.48% over the past month, fell 14.25% over the past three months and fell 11.24% over the past year. The 14-day RSI of 66.8 is in the bullish zone, below the overbought line, and the MACD line is positive.
New analyst coverage ›
Guggenheim started coverage at Buy on September 15, 2026.
Source: Analyst action, Guggenheim, September 15, 2026
Earnings beat, but the stock fell ›
The July 29, 2026 report beat the EPS estimate by 10.21%, and the share price fell 8.61% in the first session after it.
Source: Earnings report, July 29, 2026Rating reaffirmed ›
RBC Capital kept its Sector Perform rating on October 15, 2026.
Source: Analyst action, RBC Capital, October 15, 2026
- Keep an eye on the two closest levels: the 200-day SMA at $306.20 sits above the price, while the 50-day SMA at $250.40 sits below it.
- A 14-day RSI of 66.8 falls in the bullish zone, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- After the July 29, 2026 report the share price fell 8.61% in the first session; LHX beat estimates in 7 of the last 7 reports.
LHX sits in mixed territory: its price is above the 50-day average of $250.40 but below the 200-day average of $306.20. Crossing above the 200-day would turn both signals up, while slipping below the 50-day would turn both down. On the way up, the first level to meet is the 200-day SMA at $306.20; on the way down, the first is the 50-day SMA at $250.40.
Momentum, with the RSI in the bullish zone, still backs the move.
Technical indicators
Momentum and trend for LHX, from its daily closes.
As of October 26, 2026, with LHX at $260.23, its 14-day RSI is 66.8 (showing bullish momentum without being overbought), its 50-day simple moving average is $250.40 and its 200-day is $306.20.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What LHX moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, LHX's 1-year correlation of daily returns is +0.22 with S&P 500 (SPY), +0.09 with Nasdaq 100 (QQQ), +0.01 with Bitcoin (BTC) and +0.21 with gold (XAU).
LHX price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
12 of 20 analysts rate it a buy or strong buy, 8 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $325.00 is 24.9% above the price.More buy ratings than three months ago ›
12 of 20 rate it a buy now, against 13 of 18 three months ago.
LHX Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 15, 2026 | RBC Capital | Maintains | Sector Perform |
| Oct 14, 2026 | Bernstein | Maintains | Outperform |
| Oct 12, 2026 | Goldman Sachs | Maintains | Buy |
| Oct 9, 2026 | TD Cowen | Maintains | Buy |
| Sep 23, 2026 | Bernstein | Maintains | Outperform |
| Sep 15, 2026 | Guggenheim | Initiates | Buy |
As of October 26, 2026, 20 Wall Street analysts cover LHX: 12 rate it a buy or strong buy, 8 a hold and 0 a sell or strong sell. Their 12-month price targets range from $241.00 to $443.00. The median LHX price target is $325.00, 24.9% above the price of $260.23.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
LHX trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
LHX trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from LHX's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much LHX tends to move, against the market and on its own.
LHX price history and drawdowns
LHX's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.37% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 36.1%, from April 2022 to October 2023, regained by October 2024.Most 1-year holds ended higher ›
74% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $35,253, against $42,015 in the S&P 500 (SPY).
LHX Drawdowns & Recovery
As of October 26, 2026, LHX's worst peak-to-trough fall over the last 10 years with dividends reinvested was -36.1% (April 2022 to October 2023); it regained that peak by October 2024, 12 months after the low, and 74% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into LHX in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: LHX trailed the S&P 500 over this period: $35,253 against $42,015.
A $10,000 investment in LHX in October 2016 would be worth about $35,253 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to LHX, and which have not.
Strongest month, January: an average of +5.06%, up in 6 of 10 years.
Weakest month, December: an average of -2.46%, up in 3 of 10 years.
This month, October: has averaged +1.92%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, LHX's strongest calendar month has been January (average +5.06%, up in 6 of 10 years) and its weakest December (average -2.46%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
LHX stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in LHX, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in LHX today could grow to about $13,705 by 2030 in the base case, with a 90th-percentile outcome near $26,631 and a 10th-percentile outcome around $7,053. The simulation models price only; at today's 1.90% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
LHX Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $357 for LHX by 2030 in the base case, from $260 today (1.4x over 4 years). The 10th-percentile path ends near $184. These are outcomes of a Monte Carlo simulation run on LHX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $202 | $282 | $392 | |
| 2028 | $190 | $305 | $487 | |
| 2029 | $185 | $330 | $586 | |
| 2030 | $184 | $357 | $693 |
Method: a lognormal simulation of LHX's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
LHX insider trading
What the people running the company have bought and sold.
LHX insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought LHX shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, LHX insiders reported 10 open-market sales worth $72.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Joanna Geraghty
Director
|
Grant | 149 | $43.9K |
| Jul 1, 2026 | David S Regnery
Director
|
Grant | 128 | $37.6K |
| Jul 1, 2026 | Christina L. Zamarro
Director
|
Grant | 128 | $37.6K |
| May 11, 2026 | Sallie B Bailey
Director
|
Grant | 661 | - |
| May 11, 2026 | Thomas A Dattilo
Director
|
Grant | 661 | - |
| May 11, 2026 | Roger B Fradin
Director
|
Grant | 661 | - |
| May 11, 2026 | Joanna Geraghty
Director
|
Grant | 661 | - |
| May 11, 2026 | Kirk S Hachigian
Director
|
Grant | 661 | $199.9K |
| May 11, 2026 | Harry B. Harris Jr
Director
|
Grant | 661 | - |
| May 11, 2026 | Lewis Hay III
Director
|
Grant | 661 | - |
| May 11, 2026 | David S Regnery
Director
|
Grant | 661 | - |
| May 11, 2026 | Edward A. Rice Jr.
Director
|
Grant | 661 | - |
| May 11, 2026 | Christina L. Zamarro
Director
|
Grant | 661 | - |
| May 5, 2026 | Melanie Rakita
Officer
|
Sell | 2.2K | $676.8K |
| May 1, 2026 | Melanie Rakita
Officer
|
Grant | 3.6K | - |
| Apr 1, 2026 | Joanna Geraghty
Director
|
Grant | 123 | $43.8K |
| Apr 1, 2026 | David S Regnery
Director
|
Grant | 105 | $37.5K |
| Apr 1, 2026 | Christina L. Zamarro
Director
|
Grant | 105 | $37.5K |
| Mar 2, 2026 | Samir Mehta
Officer
|
Sell | 5.5K | $2.0M |
| Mar 2, 2026 | Melanie Rakita
Officer
|
Sell | 3.1K | $1.1M |
| Feb 26, 2026 | Christopher E Kubasik
Chief Executive Officer
|
Grant | 48.2K | - |
| Feb 26, 2026 | Samir Mehta
Officer
|
Grant | 9.1K | - |
| Feb 26, 2026 | Melanie Rakita
Officer
|
Grant | 1.0K | - |
| Feb 26, 2026 | Jon Rambeau
Officer
|
Grant | 9.1K | - |
| Feb 24, 2026 | Christopher E Kubasik
Chief Executive Officer
|
Grant | 16.1K | - |
| Feb 24, 2026 | Samir Mehta
Officer
|
Grant | 3.0K | - |
| Feb 24, 2026 | Melanie Rakita
Officer
|
Grant | 340 | - |
| Feb 24, 2026 | Jon Rambeau
Officer
|
Grant | 3.0K | - |
| Feb 6, 2026 | Robert B Millard
Director
|
Grant | 5.8K | - |
| Feb 5, 2026 | Samir Mehta
Officer
|
Sell | 4.8K | $1.6M |
| Jan 30, 2026 | Samir Mehta
Officer
|
Grant | 7.3K | - |
| Jan 30, 2026 | Melanie Rakita
Officer
|
Grant | 1.5K | - |
| Jan 2, 2026 | Joanna Geraghty
Director
|
Grant | 143 | $43.8K |
| Jan 2, 2026 | Robert B Millard
Director
|
Grant | 123 | $37.5K |
| Jan 2, 2026 | David S Regnery
Director
|
Grant | 123 | $37.5K |
| Jan 2, 2026 | Christina L. Zamarro
Director
|
Grant | 123 | $37.5K |
| Nov 13, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Sell | 14.2K | $4.3M |
| Nov 13, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Option | 14.2K | $2.3M |
| Nov 13, 2025 | Edward J Zoiss
Officer
|
Grant | 1.1K | - |
| Oct 31, 2025 | Jon Rambeau
Officer
|
Grant | 4.1K | - |
| Oct 1, 2025 | Joanna Geraghty
Director
|
Grant | 145 | $43.8K |
| Oct 1, 2025 | Robert B Millard
Director
|
Grant | 124 | $37.5K |
| Oct 1, 2025 | David S Regnery
Director
|
Grant | 124 | $37.5K |
| Oct 1, 2025 | Christina L. Zamarro
Director
|
Grant | 124 | $37.5K |
| Sep 12, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Sell | 83.0K | $23.2M |
| Sep 12, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Option | 83.0K | $13.5M |
| Aug 11, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Sell | 40.1K | $10.8M |
| Aug 11, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Option | 40.1K | $6.0M |
| Jul 29, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Sell | 72.0K | $19.5M |
| Jul 29, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Option | 72.0K | $10.8M |
| Jul 1, 2025 | Joanna Geraghty
Director
|
Grant | 168 | $42.6K |
| Jul 1, 2025 | Robert B Millard
Director
|
Grant | 158 | $40.0K |
| Jul 1, 2025 | David S Regnery
Director
|
Grant | 148 | $37.5K |
| Jul 1, 2025 | Christina L. Zamarro
Director
|
Grant | 148 | $37.5K |
| Jun 12, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Sell | 35.3K | $8.8M |
| Jun 12, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Option | 35.3K | $4.6M |
| May 30, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Grant | 6.7K | - |
| May 27, 2025 | Edward J Zoiss
President
|
Sell | 2.0K | $490.0K |
| May 2, 2025 | Christopher E Kubasik
Chief Executive Officer
|
Grant | 1.2K | - |
Source: TwelveData, from SEC Form 4 filings
LHX stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.